Bright Biotech
3 known investors
Bright Biotech produces recombinant proteins, including growth factors, by expressing them in plant chloroplasts. Its proteins are aimed at cell culture and regenerative medicine applications.
Investors · 3
Companies House · registry record
View on Companies House ↗- Registered name
- BRIGHT BIOTECH LIMITED
- Company number
- 12253910
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 10 Oct 2019
- Registered office
- Rutherford House Unit 16 Pencroft Way, Manchester Science Park, Manchester, M15 6SZ
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 20 Sept 2025 · next due 4 Oct 2026
Current officers · 4
- Mohammad Farid Khan — secretary, appointed 10 Oct 2019
- Mohammad El Hajj — director, appointed 10 Oct 2019
- Adrian Friederich — director, appointed 30 Apr 2025
- Mohammad Farid Khan — director, appointed 3 Oct 2022
Source: Companies House public register · retrieved 23 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Bright Biotech do?
- Bright Biotech produces recombinant proteins, including growth factors, by expressing them in plant chloroplasts. Its proteins are aimed at cell culture and regenerative medicine applications.
- Who are Bright Biotech's investors?
- Bright Biotech's investors include Big Idea Ventures, FoodLabs, CPT Capital.